An Interpretable Deep Learning Approach for Autism Spectrum Disorder Detection in Children Using NASNet-Mobile.

Publication date: May 22, 2025

Autism spectrum disorder (ASD) is a multifaceted neurodevelopmental disorder featuring impaired social interactions and communication abilities engaging the individuals in a restrictive or repetitive behaviour. Though incurable early detection and intervention can reduce the severity of symptoms. Structural magnetic resonance imaging (sMRI) can improve diagnostic accuracy, facilitating early diagnosis to offer more tailored care. With the emergence of deep learning (DL), neuroimaging-based approaches for ASD diagnosis have been focused. However, many existing models lack interpretability of their decisions for diagnosis. The prime objective of this work is to perform ASD classification precisely and to interpret the classification process in a better way so as to discern the major features that are appropriate for the prediction of disorder. The proposed model employs neural architecture search network – mobile(NASNet-Mobile) model for ASD detection, which is integrated with an explainable artificial intelligence (XAI) technique called local interpretable model-agnostic explanations (LIME) for increased transparency of ASD classification. The model is trained on sMRI images of two age groups taken from autism brain imaging data exchange-I (ABIDE-I) dataset. The proposed model yielded accuracy of 0. 9607, F1-score of 0. 9614, specificity of 0. 9774, sensitivity of 0. 9451, negative predicted value (NPV) of 0. 9429, positive predicted value (PPV) of 0. 9783 and the diagnostic odds ratio of 745. 59 for 2 to 11 years age group compared to 12 to 18 years group. These results are superior compared to other state of the art models Inception v3 and SqueezeNet.

Concepts Keywords
Agnostic ABIDE-I
F1 Accuracy
Neurodevelopmental ASD
Transparency DL
LIME
NASNet-Mobile
XAI

Semantics

Type Source Name
disease MESH Autism Spectrum Disorder
disease MESH neurodevelopmental disorder
drug DRUGBANK Tropicamide
disease MESH autism

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *